4-Methoxycarbonyl-2-amino-thiophenol | 203664-49-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Methoxycarbonyl-2-amino-thiophenol
• 英文别名: 3-amino-4-mercapto-benzoic acid methyl ester；methyl 3-amino-4-mercaptobenzoate；Methyl3-amino-4-mercaptobenzoate；methyl 3-amino-4-sulfanylbenzoate
• CAS: 203664-49-7
• 化学式: C₈H₉NO₂S
• 分子量: 183.231
• InChiKey: ZCKPTTBRWYHPOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  53.3
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-Methoxycarbonyl-2-amino-thiophenol 以 甲醇 为溶剂， 反应 1.0h， 生成 2,2,2',2'-tetramethyl-2,3,2',3',4',5'-hexahydro-4,4'-prop-1-en-1-yl-3-ylidene-bis-benzo[b][1,4]thiazepine-7-carboxylic acid dimethyl ester
  参考文献：
  名称：

  Mushkalo,L.K.; Chuiguk,V.A., Soviet progress in chemistry, 1969, vol. 35, # 6, p. 55 - 58

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氯-3-硝基苯甲酸 在 盐酸 作用下， 生成 4-Methoxycarbonyl-2-amino-thiophenol
  参考文献：
  名称：

  THE SYNTHESIS OF 2-AMINOBENZENETHIOL HYDROCHLORIDES

  摘要：

  不可用。

  DOI：

  10.1139/v65-358

文献信息

• Benzopiperidine derivatives
  申请人：Eisai Co., Ltd.

  公开号：US06518423B1

  公开（公告）日：2003-02-11

  Benzopiperidine derivatives represented by formula (I), salts thereof or hydrates thereof, processes for producing the same and drugs comprising the same: wherein the variables are as described in the specification. These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and rejection reaction accompanying organ transplantation.

  本茨哌啶衍生物，由公式(I)表示，其盐或水合物，其制备方法以及包含其的药物: 其中变量如说明书中所述。这些化合物作为药物有效，用于预防和治疗这些各种炎症性疾病和免疫性疾病，如类风湿性关节炎、特应性皮炎、银屑病、哮喘和伴随器官移植的排斥反应。
• Benzothiazole cyclobutyl amine derivatives
  申请人：Cowart D. Marlon

  公开号：US20070066588A1

  公开（公告）日：2007-03-22

  Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

  公式（I）的化合物在治疗由组胺-3受体配体预防或改善的疾病或疾病中是有用的。还公开了包含组胺-3受体配体的药物组合物，使用这类化合物和组合物的方法，以及制备公式（I）范围内化合物的过程。
• Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA
  申请人：Phillion P. Dennis

  公开号：US20050009054A1

  公开（公告）日：2005-01-13

  The present invention is directed to the means by which to alter the binding affinity and/or specificity of a compound with a sequence of DNA in the minor groove of a double-strand thereof. More particularly, the present invention is directed to a synthetic and/or non-naturally occurring compound (e.g., an analog of a polyamide oligomer or polymer) which contains at least one hydrogen bond donor moiety and at least one hydrogen bond acceptor moiety, wherein the latter moiety or “building block” has a fused, bicyclic structure which is heteroaromatic, said structure having a heteroatom therein which acts as a hydrogen bond acceptor to bind guanine in the minor groove of the dsDNA sequence, and which is incapable of forming a tautomer. In one particular embodiment of the synthetic and/or non-naturally occurring compound, the fused, bicyclic structure occupies an initial or first terminal position within the compound.

  本发明涉及一种改变化合物与DNA双链中小沟的序列的结合亲和力和/或特异性的方法。特别地，本发明涉及一种合成和/或非自然存在的化合物（例如，聚酰胺寡聚物或聚合物的类似物），该化合物含有至少一个氢键供体基团和至少一个氢键受体基团，其中后者基团或“构建块”具有融合的、杂环芳香性的双环结构，该结构在其中具有作为氢键受体以结合双链DNA序列中的鸟嘌呤的杂原子，并且不能形成互变异构体。在合成和/或非自然存在的化合物的一个特定实施例中，融合的、双环结构占据化合物的初始或第一端位置。
• BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES
  申请人：Cowart Marlon D.

  公开号：US20090326222A1

  公开（公告）日：2009-12-31

  Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

  公式（I）的化合物在治疗由组胺-3受体配体预防或改善的疾病或疾病方面非常有用。还公开了包含组胺-3受体配体的药物组合物，使用此类化合物和组合物的方法以及制备公式（I）范围内化合物的过程。
• [EN] CBL-B MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE CBL-B ET LEURS UTILISATIONS
  申请人：NIMBUS CLIO INC

  公开号：WO2022272248A1

  公开（公告）日：2022-12-29

  The invention provides compounds, compositions thereof, and methods of using the same for the inhibition of Cb1-b, and the treatment of a variety of Cb1-b-mediated diseases, disorders or conditions, associated with modulating the immune system implicating Cb1-b. Compounds are also useful for the study of Cb1-b enzymes in biological and pathological phenomena; the study of ubiquitination occurring in bodily tissues; and the comparative evaluation of new Cb1-b inhibitors or other regulators of cell cycle, DNA repair, differentiation, and innate and adaptive immunity in vitro or in vivo.

  本发明提供了用于抑制 Cb1-b 和治疗各种 Cb1-b 介导的疾病、失调或病症的化合物、其组合物和使用方法，这些疾病、失调或病症与调节涉及 Cb1-b 的免疫系统有关。化合物还可用于研究生物和病理现象中的 Cb1-b 酶；研究身体组织中发生的泛素化；以及比较评估体外或体内新的 Cb1-b 抑制剂或细胞周期、DNA 修复、分化以及先天性和适应性免疫的其他调节剂。